EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Arginase 2 deficiency mitigates sepsis‐associated acute kidney injury by alleviating lipid accumulation

Yu Xin, Yanqi Liu, Ning Zhang, Pengfei Huang, Qianqian Zhang, Yinghao Luo, Xinran Wang, Xiuhua Zhang, Tao Wu, Fengye Liu, Yu Xiao, Lifeng Shen und 12 weitere

Clinical and Translational Medicine · 2026-09 · 16 (9)

DOI: 10.1002/ctm2.70770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 18.09.2026. Verfasst von Yu Xin und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Arginase, Sepsis, Lipid Metabolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Zhejiang Provincial Applied Basic Research Program Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis‐associated acute kidney injury (S‐AKI) imposes substantial morbidity and mortality burdens in critically ill populations. This study aimed to construct a spatiotemporal multi‐omics atlas of kidneys in a mouse model of S‐AKI using spatial metabolomics and proteomics, and to explore potential therapeutic targets for S‐AKI.

Methods

A spatiotemporal multi‐omics atlas of S‐AKI mouse kidneys was constructed using spatial metabolomics and proteomics. Arginine metabolism was evaluated via L‐arginine supplementation. ARG2 was inhibited by nor‐NOHA or renal tubule‐specific knockdown. Kidney injury was assessed by histopathology, real‐time glomerular filtration rate (RT‐GFR), serum serum urea nitrogen (BUN), and injury markers. RNA‐seq and serum metabolomics elucidated nor‐NOHA's mechanism, with in vivo verification of pathway activation and lipid reduction. In vitro studies used ARG2 KO renal primary tubular epithelial cells (RPTCs) and kidney organoids.

Results

Arginine metabolism played a crucial role, but L‐arginine supplementation did not improve renal function. ARG2 was significantly upregulated in proximal and distal tubules of the renal outer medulla and in macrophages. Treatment with the arginase inhibitor nor‐NOHA or knockdown of ARG2 in renal tubules significantly alleviated kidney injury, as evidenced by reduced tubular injury, increased RT‐GFR, decreased BUN, and reduced injury markers. RNA‐seq and serum metabolomics showed that nor‐NOHA significantly reduced lipid accumulation in renal tubules and serum, with significant enrichment of the peroxisome proliferator‐activated receptor (PPAR) pathway centered around PPARγ. In vivo experiments confirmed pathway activation and alleviation of lipid accumulation. In vitro experiments using RPTCs from ARG2 knockout mice and human kidney organoid model revealed that ARG2 knockout restored PPARγ expression and reduced tubular lipid accumulation.

Conclusions

Inhibiting ARG2 in renal tubules during S‐AKI may alleviate lipid accumulation and kidney injury by activating PPARγ, providing a new therapeutic strategy. Key points Spatiotemporal multi‐omics analysis constructed a detailed atlas of S‐AKI kidneys, revealing the regional specificity of metabolic and protein expression in different kidney regions during the progression from sepsis to S‐AKI. Arginine metabolism plays a key role in the pathogenesis of S‐AKI, with arginine levels continuously decreasing in S‐AKI and significantly correlating with renal function. In S‐AKI, ARG2 expression increases, mainly localizing to renal tubular cells and macrophages. Renal tubule—specific ARG2 knockdown reduces renal tubular lipid accumulation and kidney injury in S‐AKI, likely playing an important role by regulating PPARγ to affect lipid accumulation. The kidney organoids with ARG2 knockout further confirmed the key role of ARG2 in S‐AKI, providing a new therapeutic target for S‐AKI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryArginaseSepsisLipid MetabolismAnimalsMiceMaleDisease Models, AnimalArginineMetabolomicsMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

L‐argininearginase 2sepsis‐associated acute kidney injuryspatial multi‐omics

Substanzen

ArginaseArg2 protein, mouseArginine

Autor:innen und Institutionen

  • Department of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Central Laboratory of The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
  • Heilongjiang provincial key laboratory of critical care medicine, Harbin, Heilongjiang Province, China.
  • Department of Critical Care Medicine, Shenzhen People's Hospital (The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China.
  • Department of Geriatrics, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The First Affiliated Hospital of Southern University…
  • Health Data Science Center, Shenzhen People's Hospital, Shenzhen, China.

ORCID-Profile: Weiting Zhang, Xianglin Meng, Xubin Zheng, Lixin Cheng, Changsong Wang

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Medical Research Fund
  • Zhejiang Provincial Applied Basic Research Program Project

Zitieren

APA

Xin, Y., Liu, Y., Zhang, N., Huang, P., Zhang, Q., Luo, Y., Wang, X., Zhang, X., Wu, T., Liu, F., Xiao, Y., Shen, L., Zhang, W., Wang, X., Meng, X., Bai, Y., Wang, X., Zhang, N., Xu, Q., …, & Wang, C. (2026). Arginase 2 deficiency mitigates sepsis‐associated acute kidney injury by alleviating lipid accumulation. Clinical and Translational Medicine, 16(9). https://doi.org/10.1002/ctm2.70770

Vancouver

Xin Y, Liu Y, Zhang N, Huang P, Zhang Q, Luo Y, et al. Arginase 2 deficiency mitigates sepsis‐associated acute kidney injury by alleviating lipid accumulation. Clinical and Translational Medicine. 2026;16(9). doi:10.1002/ctm2.70770

BibTeX
@article{Xin2026,
  author = {Xin, Yu and Liu, Yanqi and Zhang, Ning and Huang, Pengfei and Zhang, Qianqian and Luo, Yinghao and Wang, Xinran and Zhang, Xiuhua and Wu, Tao and Liu, Fengye and Xiao, Yu and Shen, Lifeng and Zhang, Weiting and Wang, Xibo and Meng, Xianglin and Bai, Yuping and Wang, Xuan and Zhang, Nan and Xu, Qianghong and Meng, Hongxue and Zheng, Xubin and Cheng, Lixin and Yu, Kaijiang and Wang, Changsong},
  title = {Arginase 2 deficiency mitigates sepsis‐associated acute kidney injury by alleviating lipid accumulation},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {9},
  doi = {10.1002/ctm2.70770}
}
Kostenlos starten →